We're raising our Eli Lilly price target – what a difference a quarter makes!
Eli Lilly shares rose Thursday after the drugmaker posted a strong third quarter, boosted by sales of its popular GLP-1…
investment strategy
Stocks of breast cancer drug Olema could more than double from now on, analysts say
Wall Street is optimistic that Olema Pharmaceuticals could be developing the next big breakthrough in breast cancer treatment. Earlier this…
This biotech stock is up almost 50% in 3 months. Its CEO says the business is “growing substantially”
It's been a stellar few months for the San Francisco-based biotech company's stock Rigel Pharmaceuticalswhich has approved treatments for hematology…
We're downgrading it, considering the next step
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified healthcare company turned in another less-than-stellar quarter. Revenue in…
How a series of bad loans makes bank investors look for hidden risks
Major banks, including JPMorgan Chase and Goldman Sachs He had just finished taking victory laps after a successful quarter when…
DuPont prepares to spin off electronics. What investors get with the remaining company
Earlier this week, we looked at the upcoming spinoff of DuPont's electronics business and what investors will get from the…
Morgan Stanley (MS) Third Quarter 2025 Results
Ted Pick, CEO of Morgan Stanley, speaks on CNBC's Squawk Box outside the World Economic Forum in Davos, Switzerland, on…
JPMorgan Chase to invest $10 billion in key industries
JPMorgan Chase On Monday he said he is launching a decade-long plan to help finance and take direct stakes in…
We are buying the sauce in a stock and health science stock that has been reduced enough
We are buying 20 more Danaher shares at approximately $ 180 each. After Thursday's trade, Jim Cramer's charitable trust will…
Jim Cramer says that Eli Lilly's obesity pill could be more a “drug for life” than the shots
Do not count Eli Lilly's oral medication for obesity and diabetes yet, according to Jim Cramer de CNBC. That was…